D'AMATO, FILOMENA
 Distribuzione geografica
Continente #
EU - Europa 70.685
NA - Nord America 1.644
AS - Asia 296
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 72.637
Nazione #
IT - Italia 70.177
US - Stati Uniti d'America 1.634
CN - Cina 207
SE - Svezia 198
UA - Ucraina 131
DE - Germania 70
FI - Finlandia 48
SG - Singapore 47
GB - Regno Unito 29
VN - Vietnam 28
CA - Canada 9
FR - Francia 9
RU - Federazione Russa 9
BR - Brasile 5
EU - Europa 4
IN - India 4
KR - Corea 4
BE - Belgio 3
CH - Svizzera 3
HK - Hong Kong 2
IR - Iran 2
RO - Romania 2
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ES - Italia 1
LT - Lituania 1
LU - Lussemburgo 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TH - Thailandia 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 72.637
Città #
Cagliari 69.258
Uta 824
Fairfield 207
Chandler 178
Woodbridge 148
Nyköping 129
Ann Arbor 112
Houston 103
Wilmington 102
Seattle 89
Ashburn 88
Boardman 73
Cambridge 68
Jacksonville 68
Dearborn 63
Shanghai 50
Dong Ket 28
Singapore 28
Helsinki 26
Santa Clara 25
Nanjing 22
Beijing 20
Boston 16
San Diego 11
Verona 11
Changsha 10
Hebei 10
Los Angeles 10
New York 10
Renton 10
San Mateo 10
Guangzhou 9
Nanchang 9
Milan 8
Redwood City 8
Rome 8
Jiaxing 7
Phoenix 7
Kunming 6
Munich 6
Shenyang 6
Toronto 6
Chicago 5
Hefei 5
Orange 5
Saint Petersburg 5
Falls Church 4
Jinan 4
Leawood 4
Mountain View 4
Seoul 4
Tianjin 4
Brussels 3
Detroit 3
London 3
Sassari 3
Taizhou 3
Atlanta 2
Auburn Hills 2
Baotou 2
Borås 2
Chongqing 2
Frankfurt am Main 2
Kilburn 2
Monza 2
Norwalk 2
Ottawa 2
Pune 2
Quartu Sant'elena 2
Romainville 2
Saint Paul 2
Sarroch 2
Tappahannock 2
Turin 2
Ardabil 1
Ashgabat 1
Auckland 1
Augusta 1
Bagé 1
Biel 1
Capoterra 1
Capranica 1
Central 1
Council Bluffs 1
Falkenstein 1
Florence 1
Foetz 1
Foshan 1
Fuzhou 1
Geneve 1
Governador Valadares 1
Groningen 1
Hangzhou 1
Hong Kong 1
Huzhou 1
Indiana 1
Jequié 1
Jinhua 1
L'aquila 1
Lanark 1
Totale 72.006
Nome #
VGF peptide profiles in Type 2 diabetic patients' plasma and in obese mice 4.663
VGF protein and its C-terminal derived peptides in amyotrophic lateral sclerosis: Human and animal model studies 4.657
Photoperiod Regulates vgf-Derived Peptide Processing in Siberian Hamsters 4.263
Profiles of VGF peptides in the rat brain and their modulations after Phencyclidine treatment 3.965
VGF: an inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers. 3.780
VGF and Type II Diabetes: Decrease of VGF fragment levels in adipose tissues of diet-induced obese mice 3.766
Selective expression of TLQP-21 and other VGF peptides in gastric neuroendocrine cells and modulation by feeding 3.753
Parkinson’s disease: changes in TLQP and related peptide/s in 6-OHDA treated rat and in human plasma 3.661
VGF-peptides in the Siberian hamster 3.616
Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases 3.510
VGF changes during the estrous cycle: a novel endocrine role for TLQP peptides? 3.267
Pituitary gonadotropins and autoimmunity 3.244
VGF peptides in hypothalamus-pituitary axis in the rat estrous cycle 3.112
Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation 3.083
Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1 2.807
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation 2.797
null 2.647
Modulation of the VGF derived peptides NERP-1 and –2 upon salt loading and dehydration: novel actors in water homeostasis? 2.513
VGF metabolic-related gene: distribution of its derived peptides in mammalian pancreatic islets 2.316
Multiple immunofluorescence technology 2.292
Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development, and increase in hyperplasia and neoplasia 1.855
BTK inhibitors synergize with 5-FU to treat drug-resistant TP53-null colon cancers 1.805
Gene inducibile VGF e surrene. Prodotti derivati da proVGF, distribuzione differenziale, possibile modulazione 681
VGF peptides upon osmotic stimuli: Changes in neuroendocrine regulatory peptides 1 and 2 in the hypothalamic-pituitary-axis and plasma 624
null 25
Totale 72.702
Categoria #
all - tutte 80.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.744 0 0 0 0 0 0 0 427 275 320 220 502
2020/202118.114 557 705 758 5.034 3.257 2.146 1.089 1.223 567 1.131 1.101 546
2021/20223.223 476 250 128 323 274 204 205 123 315 339 301 285
2022/20234.339 301 626 687 340 315 347 235 275 340 325 362 186
2023/20243.658 324 314 146 215 350 511 550 246 265 204 272 261
2024/20254.406 932 1.166 733 537 305 318 393 22 0 0 0 0
Totale 72.702